NCT01585636View on ClinicalTrials.gov

Escalating Single-dose Safety, Tolerability, and Pharmacokinetics of SQ109 in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

62

Participants

Timeline

Start Date

September 30, 2006

Primary Completion Date

February 28, 2007

Study Completion Date

February 28, 2007

Conditions
Tuberculosis
Interventions
DRUG

SQ109

Single oral dose

Trial Locations (1)

66219

Quintiles Phaes 1 Clinical Study Unit, Lenexa

All Listed Sponsors
collaborator

Quintiles, Inc.

INDUSTRY

lead

Sequella, Inc.

INDUSTRY

NCT01585636 - Escalating Single-dose Safety, Tolerability, and Pharmacokinetics of SQ109 in Healthy Volunteers | Biotech Hunter | Biotech Hunter